News & Updates
Showing Multidisciplinary articles
Showing
Vebicorvir plus entecavir safe, effective in chronic HBV patients
The addition of vebicorvir to entecavir in treatment-naïve patients with chronic hepatitis B virus (HBV) infection provides further antiviral activity, with a positive safety and tolerability profile, results of a phase II trial have shown.
Serum cholesterol efflux capacity underpins early AMD
Patients with early age-related macular degeneration (eAMD) appear to have increased serum cholesterol efflux capacity, according to a recent Singapore study. The same is true for polypoidal choroidal vasculopathy (PCV), but not for typical neovascular AMD (tAMD).
NADIM II suggests PFS, OS benefits of nivolumab + chemo in resectable NSCLC
Adding nivolumab to paclitaxel-carboplatin chemotherapy in the neoadjuvant setting boosted progression-free survival (PFS) and overall survival (OS) in patients with resectable stage IIIA–B non-small cell lung cancer (NSCLC), according to results of the phase II NADIM II trial from Spain.
Finerenone shields against pneumonia, COVID-19 in diabetic patients with CKD
Patients with concomitant chronic kidney disease (CKD) and type 2 diabetes (T2D) who are undergoing mineralocorticoid receptor blockade with finerenone are better protected against pneumonia and COVID-19, according to a secondary analysis of data from the FIDELITY trials.
Freshwater fish-based diet eases liver steatosis in NAFLD patients
Adherence to a freshwater fish-based diet helps regulate the gut microbiota and its metabolites, suggesting benefits in individuals with nonalcoholic fatty liver disease (NAFLD), reveals a study.